Format

Send to

Choose Destination
ScientificWorldJournal. 2011 Apr 5;11:855-65. doi: 10.1100/tsw.2011.84.

Cannabinoids and innate immunity: taking a toll on neuroinflammation.

Author information

1
Institute of Immunology, National University of Ireland Maynooth, County Kildare, Ireland. Eric.Downer@nuim.ie

Abstract

The biologically active components of cannabis have therapeutic potential in neuroinflammatory disorders due to their anti-inflammatory propensity. Cannabinoids influence immune function in both the peripheral and the central nervous system (CNS), and the components of the cannabinoid system, the cannabinoid receptors and their endogenous ligands (endocannabinoids), have been detected on immune cells as well as in brain glia. Neuroinflammation is the complex innate immune response of neural tissue to control infection and eliminate pathogens, and Toll-like receptors (TLRs), a major family of pattern recognition receptors (PRRs) that mediate innate immunity, have emerged as players in the neuroinflammatory processes underpinning various CNS diseases. This review will highlight evidence that cannabinoids interact with the immune system by impacting TLR-mediated signaling events, which may provide cues for devising novel therapeutic approaches for cannabinoid ligands.

PMID:
21479354
PMCID:
PMC5720096
DOI:
10.1100/tsw.2011.84
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Hindawi Limited Icon for PubMed Central
Loading ...
Support Center